Pulse Biosciences Inc PLSE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
-
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026
-
Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment
-
Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules
-
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results
Trading Information
- Previous Close Price
- $45.59
- Day Range
- $43.32–46.67
- 52-Week Range
- $12.56–58.90
- Bid/Ask
- $41.05 / $51.98
- Shares Outstanding
- 71.32M
- Market Cap
- $3.17B
- Volume/Avg
- 327,426 / 511,778
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2,789.33
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 116
- Website
- https://www.pulsebiosciences.com
Valuation
|
Metric
|
PLSE
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 34.54 |
Price/Sales | 2,789.33 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PLSE
|
|---|---|
Quick Ratio | 9.27 |
Current Ratio | 9.63 |
Interest Coverage | — |
Quick Ratio
PLSE
Profitability
|
Metric
|
PLSE
|
|---|---|
Return on Assets (Normalized) | −59.11% |
Return on Equity (Normalized) | −69.38% |
Return on Invested Capital (Normalized) | −67.10% |
Return on Assets
PLSE
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|#hRD&pf | LOCK|Js | $151B | |||
| Becton Dickinson & Co
BDX
| LOCK|V^W | LOCK|Ynd$L | $52B | |||
| ResMed Inc
RMD
| LOCK|?t^<T<$? | LOCK|fX$rt | $34B | |||
| Alcon Inc
ALC
| LOCK|^#j&$K$ | LOCK|Qs&>B | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|&$DqHFy | LOCK|f<Xy | $32B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|yq<cNCq! | LOCK|kMZ | $27B | |||
| Solventum Corp
SOLV
| LOCK|#R<##l% | LOCK|C^$ | $15B | |||
| Baxter International Inc
BAX
| LOCK|ym | LOCK|qD<%l | $13B | |||
| Repligen Corp
RGEN
| LOCK|m$<y!%!< | LOCK|p!S? | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|<T!bj<h | LOCK|rZ<l^ | $11B |
United States